Fortis Healthcare Share Price
Sector: Healthcare Facilities
700.30 +0.35 (0.05%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
696.00
Today’s High
709.00
52 Week Low
406.35
52 Week High
744.00
700.05 +0.65 (0.09%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
695.30
Today’s High
709.05
52 Week Low
406.00
52 Week High
744.50
Key Metrics
- Market Cap (In Cr) 52869.72
- Beta 1.02
- Div. Yield (%) 0.14
- P/B 6.9
- TTM P/E 70.7
- Sector P/E 23.18
- Open Price 703
- Prev Close 699.95
Fortis Healthcare Analysis
Price Analysis
-
1 Week5.32%
-
3 Months15.93%
-
6 Month9.54%
-
YTD-2.75%
-
1 Year55.97%
Risk Meter
- 37% Low risk
- 37% Moderate risk
- 37% Balanced Risk
- 37% High risk
- 37% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 4
- 4
- 4
- 4
- Buy
- 8
- 8
- 8
- 8
- Hold
- 0.00
- 0.00
- 0.00
- 0.00
- Sell
- 1
- 1
- 1
- 1
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 13
- 13
- 13
- 13
Fortis Healthcare News
Best stock recommendations today: MarketSmith India's top picks for 7 May
3 min read . 07 May 2025Stocks to watch: Indian Hotels, Paytm, BSE among shares in focus today
2 min read . 06 May 2025Delhi eyebig pvt hospitals for health insurance. They have concerns
3 min read . 23 Apr 2025Fortis Healthcare Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 6892.92
- Selling/ General/ Admin Expenses Total
- 3764.77
- Depreciation/ Amortization
- 342.5
- Other Operating Expenses Total
- 11.77
- Total Operating Expense
- 5951.4
- Operating Income
- 941.51
- Net Income Before Taxes
- 857.97
- Net Income
- 598.88
- Diluted Normalized EPS
- 7.74
- Period
- 2024
- Total Assets
- 13288.78
- Total Liabilities
- 5625.88
- Total Equity
- 7662.9
- Tangible Book Valueper Share Common Eq
- 40.47
- Period
- 2024
- Cashfrom Operating Activities
- 1100.1
- Cashfrom Investing Activities
- -886.37
- Cashfrom Financing Activities
- -86.46
- Net Changein Cash
- 124.52
- Period
- 2023
- Total Revenue
- 6297.63
- Selling/ General/ Admin Expenses Total
- 3504.95
- Depreciation/ Amortization
- 315.74
- Other Operating Expenses Total
- 11.43
- Total Operating Expense
- 5438.42
- Operating Income
- 859.22
- Net Income Before Taxes
- 813.68
- Net Income
- 588.73
- Diluted Normalized EPS
- 6.87
- Period
- 2023
- Total Assets
- 12433.6
- Total Liabilities
- 5191.34
- Total Equity
- 7242.26
- Tangible Book Valueper Share Common Eq
- 35.3
- Period
- 2023
- Cashfrom Operating Activities
- 822.23
- Cashfrom Investing Activities
- -373.7
- Cashfrom Financing Activities
- -471.22
- Net Changein Cash
- -21.46
- Period
- 2022
- Total Revenue
- 5717.61
- Selling/ General/ Admin Expenses Total
- 3063.26
- Depreciation/ Amortization
- 300.84
- Other Operating Expenses Total
- 11.16
- Total Operating Expense
- 4642.55
- Operating Income
- 1075.06
- Net Income Before Taxes
- 987.79
- Net Income
- 555.12
- Diluted Normalized EPS
- 3.98
- Period
- 2022
- Total Assets
- 11884.75
- Total Liabilities
- 5706.51
- Total Equity
- 6178.24
- Tangible Book Valueper Share Common Eq
- 22.69
- Period
- 2022
- Cashfrom Operating Activities
- 879.11
- Cashfrom Investing Activities
- -514.38
- Cashfrom Financing Activities
- -517.31
- Net Changein Cash
- -152.52
- Period
- 2021
- Total Revenue
- 4030.12
- Selling/ General/ Admin Expenses Total
- 2424.81
- Depreciation/ Amortization
- 290.6
- Other Operating Expenses Total
- 24.06
- Total Operating Expense
- 3902.96
- Operating Income
- 127.16
- Net Income Before Taxes
- 43.3
- Net Income
- -109.76
- Diluted Normalized EPS
- -1.48
- Period
- 2021
- Total Assets
- 11154.69
- Total Liabilities
- 5034.88
- Total Equity
- 6119.81
- Tangible Book Valueper Share Common Eq
- 30.92
- Period
- 2021
- Cashfrom Operating Activities
- 485.49
- Cashfrom Investing Activities
- -135.1
- Cashfrom Financing Activities
- -142.93
- Net Changein Cash
- 212.01
- Period
- 2020
- Total Revenue
- 4632.32
- Selling/ General/ Admin Expenses Total
- 2841.78
- Depreciation/ Amortization
- 291.73
- Other Operating Expenses Total
- 13.72
- Total Operating Expense
- 4251.83
- Operating Income
- 380.49
- Net Income Before Taxes
- 239.36
- Net Income
- 57.94
- Diluted Normalized EPS
- 0.24
- Period
- 2020
- Total Assets
- 11347.82
- Total Liabilities
- 4686.73
- Total Equity
- 6661.09
- Tangible Book Valueper Share Common Eq
- 37.94
- Period
- 2020
- Cashfrom Operating Activities
- 171.54
- Cashfrom Investing Activities
- 60.42
- Cashfrom Financing Activities
- -861.61
- Net Changein Cash
- -626.59
- Period
- 2019
- Total Revenue
- 4469.36
- Selling/ General/ Admin Expenses Total
- 3107.42
- Depreciation/ Amortization
- 231.81
- Other Operating Expenses Total
- 7.24
- Total Operating Expense
- 4686.9
- Operating Income
- -217.54
- Net Income Before Taxes
- -110.1
- Net Income
- -298.94
- Diluted Normalized EPS
- -1.84
- Period
- 2019
- Total Assets
- 11951.27
- Total Liabilities
- 5350.47
- Total Equity
- 6600.8
- Tangible Book Valueper Share Common Eq
- 36.95
- Period
- 2019
- Cashfrom Operating Activities
- -87.62
- Cashfrom Investing Activities
- -3322.74
- Cashfrom Financing Activities
- 4256.61
- Net Changein Cash
- 798.76
- Period
- 2024-12-31
- Total Revenue
- 1928.26
- Selling/ General/ Admin Expenses Total
- 708.01
- Depreciation/ Amortization
- 97.33
- Other Operating Expenses Total
- 391.66
- Total Operating Expense
- 1626.67
- Operating Income
- 301.59
- Net Income Before Taxes
- 279.39
- Net Income
- 247.9
- Diluted Normalized EPS
- 2.99
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 1988.39
- Selling/ General/ Admin Expenses Total
- 699.15
- Depreciation/ Amortization
- 95.05
- Other Operating Expenses Total
- 393.57
- Total Operating Expense
- 1708.38
- Operating Income
- 280.01
- Net Income Before Taxes
- 261.05
- Net Income
- 176.46
- Diluted Normalized EPS
- 2.93
- Period
- 2024-09-30
- Total Assets
- 13596.82
- Total Liabilities
- 5749.54
- Total Equity
- 7847.28
- Tangible Book Valueper Share Common Eq
- 43.09
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 531.4
- Cashfrom Investing Activities
- -307.69
- Cashfrom Financing Activities
- -315.41
- Net Changein Cash
- -91.64
- Period
- 2024-06-30
- Total Revenue
- 1858.9
- Selling/ General/ Admin Expenses Total
- 688.87
- Depreciation/ Amortization
- 91
- Other Operating Expenses Total
- 374.65
- Total Operating Expense
- 1607.18
- Operating Income
- 251.72
- Net Income Before Taxes
- 230.05
- Net Income
- 165.96
- Diluted Normalized EPS
- 2.2
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 1785.88
- Selling/ General/ Admin Expenses Total
- 641.3
- Depreciation/ Amortization
- 92.23
- Other Operating Expenses Total
- 349.87
- Total Operating Expense
- 1493.94
- Operating Income
- 291.94
- Net Income Before Taxes
- 271.38
- Net Income
- 178.73
- Diluted Normalized EPS
- 2.33
- Period
- 2024-03-31
- Total Assets
- 13288.78
- Total Liabilities
- 5625.88
- Total Equity
- 7662.9
- Tangible Book Valueper Share Common Eq
- 40.47
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 1100.1
- Cashfrom Investing Activities
- -886.37
- Cashfrom Financing Activities
- -86.46
- Net Changein Cash
- 124.52
- Period
- 2023-12-31
- Total Revenue
- 1679.68
- Selling/ General/ Admin Expenses Total
- 644.73
- Depreciation/ Amortization
- 86.91
- Other Operating Expenses Total
- 357.21
- Total Operating Expense
- 1474.91
- Operating Income
- 204.77
- Net Income Before Taxes
- 183.15
- Net Income
- 134.67
- Diluted Normalized EPS
- 1.71
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Fortis Healthcare Technical
Moving Average
SMA
- 5 Day687.17
- 10 Day681.24
- 20 Day675.19
- 50 Day654.86
- 100 Day654
- 300 Day623.61
Fortis Healthcare Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Max Healthcare Institute
- 1166
- -20.7
- -1.74
- 1227.5
- 743
- 113037.43
- Apollo Hospitals Enterprise
- 7000
- -71.3
- -1.01
- 7545.1
- 5690.8
- 100649.26
- Fortis Healthcare
- 700.3
- 0.35
- 0.05
- 744
- 406.35
- 52869.72
- Narayana Hrudayalaya
- 1772
- -19.15
- -1.07
- 1872.85
- 1087.8
- 36322.24
- Global Health
- 1202.65
- -40.55
- -3.26
- 1430
- 936.05
- 32361.53
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Max Healthcare Institute
- 107.72
- 13.49
- 10.89
- 15.02
- Apollo Hospitals Enterprise
- 112.1
- 14.54
- 13.57
- 4.82
- Fortis Healthcare
- 90.45
- 6.9
- 5.07
- 7.63
- Narayana Hrudayalaya
- 45.41
- 12.58
- 23.44
- 9.72
- Global Health
- 62.23
- 9.53
- 14.18
- 11.38
Fortis Healthcare Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 20-May-25
- Audited Results & Final Dividend
- 07-Feb-25
- Quarterly Results
- 08-Nov-24
- Quarterly Results
- 09-Oct-24
- Others
- 30-Aug-24
- To consider Fund Raising
- 06-Aug-24
- Quarterly Results
- 23-May-24
- Audited Results & Final Dividend
- 07-Feb-24
- Quarterly Results
- 10-Nov-23
- Quarterly Results
- 04-Aug-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 22-Mar-25
- 19-Feb-25
- POM
- 07-Oct-24
- 05-Sept-24
- POM
- 02-Aug-24
- 11-Jul-24
- AGM
- 01-Apr-24
- 29-Feb-24
- POM
- 03-Jan-24
- 04-Dec-23
- POM
- 08-Dec-23
- 07-Nov-23
- POM
- 09-Sept-23
- 09-Aug-23
- POM
- 01-Aug-23
- 23-May-23
- AGM
- 01-Jul-23
- 02-Jun-23
- POM
- 01-Aug-22
- 21-Jun-22
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 23-May-24
- 24-Jul-24
- 24-Jul-24
- 1
- 24-May-23
- 20-Jul-23
- 20-Jul-23
- 1


